Close Menu

NEW YORK – Lunaphore Technologies, a developer of microfluidic tissue autostainers, announced on Thursday a first closing of a CHF 23 million ($23.6 million) Series C financing round.

The Lausanne, Switzerland-based company said it will invest the proceeds from the financing in market and product expansion, including entering the US market, ramping up activities in Europe, and developing a next generation of instruments.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.